森松國際(02155.HK)上半年實現純利1.44億元
格隆匯8月20日丨森松國際(02155.HK)發佈公吿,截至2021年6月30日止6個月,實現收益人民幣18.53億元,同比增長約28.48%;公司權益股東應占溢利人民幣1.44億元,基本每股盈利人民幣0.19元。
公吿表示,報吿期間集團收益增長主要歸因於化工行業產品交付大幅增長,應用於高性能化學材料、可降解塑料原材料、工業廢料處理等新型化工領域產品的強勢增長;及製藥行業因新冠疫苗和生物製藥領域的訂單增多,上半年交付增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.